CurifyLabs Welcomes a New Board and Chairman: Martti Hedman
We are excited to announce a new chapter in CurifyLabs’ journey of innovation and growth. With the appointment of a new Board of Directors, we are proud to welcome Martti Hedman as the Chairman of the Board, and Janne Laakso as a new Board Member.
Juha Lindfors, Partner at Lifeline Ventures and Founders Niklas Sandler and Charlotta Topelius continue in the board.
About Martti Hedman
Martti brings a wealth of experience from a distinguished international career spanning over three decades in the pharmaceutical and life sciences industries. His expertise will be invaluable as CurifyLabs continues to scale its operations and deliver next-generation solutions for non-sterile compounding.
Throughout his career, Martti has held prominent leadership roles, including for instance:
- Chief Executive Officer at DFE Pharma leading global operations and strategic growth.
- CEO, VP of Global Commercial Operations, and President of EMEA at Colorcon
- Board Member at Satatuote and Galena Pharma Oy, guiding strategic direction.
- Member of the Board at Ecobio Oy, focusing on sustainable business practices.
- Former Board Member at DelSiTech Ltd, a pioneer in drug delivery solutions.
His deep expertise in global strategy, operational excellence, and pharmaceutical innovation positions him to lead CurifyLabs’ Board through its next growth phase. Martti has lived and worked in U.S. and Germany and this market knowledge will also be valuable for CurifyLabs going forward.
Welcoming Janne Laakso to the Board
We are equally delighted to announce that Janne Laakso has been elected as a new member of the Board.
Janne brings a strong background in business leadership, entrepreneurship and software product development. He also holds several board positions for instance at Cerenion and SEO AI. His insights into commercial scaling will strengthen the Board’s capability to guide CurifyLabs’ ambitious growth plans. Janne’s practical and strategic mindset complements the diverse experience of the Board, ensuring robust support for CurifyLabs’ next development stages.
A Vision for the Future
The appointment of Martti Hedman as Chairman and Janne Laakso to the Board is an important milestone for CurifyLabs. Their leadership will guide the company’s strategic vision to revolutionize personalized medicine by advancing pharmaceutical 3D printing and automated medication manufacturing.
A Message from Our CEO
“Welcoming Martti Hedman as Chairman and Janne Laakso to our Board signals a transformative step for CurifyLabs. Their combined expertise will be invaluable as we continue our journey to reshape non-sterile compounding. I am excited for the road ahead.” said Charlotta Topelius, CEO of CurifyLabs.
At CurifyLabs, we are committed to pioneering the future of personalized medicine — making it accessible, safe, and effective. With a revitalized Board and strong leadership, we are better equipped than ever to deliver on this promise!
In the picture from left: Juha Lindfors, Janne Laakso, Charlotta Topelius and Martti Hedman. Missing Niklas Sandler Topelius who was at the time visiting our customer in the U.S.
